Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
37972
CAS Number:
123663-49-0
Iguratimod
Purity:
≥ 98 % (HPLC)
Synonym(s):
N- (3-Formamido-4-oxo-6-fenoxi- 4H- cromen-7-il)metanosulfonamida, N- [7-(Metanesulfonamido)-4-oxo-6-fenoxi- 4H- cromen-3-il]formamida
Documents
$61.19 /25 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
N- (3-Formamido-4-oxo-6-fenoxi- 4H- cromen-7-il)metanosulfonamida, N- [7-(Metanesulfonamido)-4-oxo-6-fenoxi- 4H- cromen-3-il]formamida
CAS Number
123663-49-0
Purity
≥ 98 % (HPLC)
Molecular Formula
C17H14N2O6S
Molecular Weight
374.37
MDL Number
MFCD00882374
PubChem ID
124246
Melting Point
238 - 242 °C
Appearance
Polvo blanco a casi blanco a cristal.
Conditions
Conservar entre 2 y 8 °C.
General Information
Synonyms
N- (3-Formamido-4-oxo-6-fenoxi- 4H- cromen-7-il)metanosulfonamida, N- [7-(Metanesulfonamido)-4-oxo-6-fenoxi- 4H- cromen-3-il]formamida
CAS Number
123663-49-0
Purity
≥ 98 % (HPLC)
Molecular Formula
C17H14N2O6S
Molecular Weight
374.37
MDL Number
MFCD00882374
PubChem ID
124246
Melting Point
238 - 242 °C
Appearance
Polvo blanco a casi blanco a cristal.
Conditions
Conservar entre 2 y 8 °C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Iguratimod is widely utilized in research focused on:

  • Rheumatoid Arthritis Treatment: This compound is primarily used as a disease-modifying antirheumatic drug (DMARD) to manage rheumatoid arthritis, helping to reduce inflammation and joint damage.
  • Immunomodulation: Iguratimod has applications in modulating the immune response, making it valuable in autoimmune disease research and therapies.
  • Pharmaceutical Development: It serves as a lead compound in the development of new anti-inflammatory medications, providing a basis for creating more effective treatments with fewer side effects.
  • Research on Chronic Inflammation: The compound is studied for its effects on chronic inflammatory conditions, offering insights into potential therapies for diseases like lupus and psoriasis.
  • Combination Therapies: Iguratimod is explored in combination with other drugs to enhance therapeutic efficacy, particularly in complex cases of autoimmune disorders.

Citas